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Introduction
Rare Diseases (RD) are a special challenge for the 
healthcare systems, because of their limited knowledge 
about their natural history, chronicity, need for long-term 
follow-up and potential high demand for assistance. 
Sound data on their prevalence and incidence are scantly 
available1 but, since they are as many as 7-8,000, it is 
estimated that, in the European Union only they affect 
about 29 million people2. Thus, the term "Registry" in the 
field of RD means more than a common epidemiologic 
tool for collection of secondary data related to patients 
with a specific RD diagnosis. Indeed, RD registries 
represent an effective way to achieve a sufficient 
sample size for epidemiological and clinical research3-5. 
Therefore, RD registries are key instruments for the 
surveillance of these diseases, with the aim of improving 
patient care and health care planning6. For these reasons 
registries are a priority at European level in the field of 
rare diseases2,7 and specific actions are being implemented 
to support the development of RD registries8.
A national institutional registry of rare disease 
patients, the Registro Nazionale Malattie Rare (RNMR), 
has been established in Italy in 2001 and is run by the 
National Centre for Rare Diseases (Centro Nazionale 
Malattie Rare, CNMR) of the Istituto Superiore di Sanità 
(National Institute of Health). Since then, the national 
and regional health authorities have cooperated for its 
implementation and after some years necessary for the 
development of the local communication networks and 
of the gradual establishment of the regional registries 
(RRs), the system achieved the full coverage of the 
national territory during 2011.
In consideration of the expected developments 
resulting from the European Union initiatives, this 
paper presents the main steps of the implementation of 
the RNMR and its main achievements, with the aim of 
sharing the RNMR experience with scientists and policy 
makers in the field of RD.
Introduction. Rare disease registries are a priority at European level and specific actions are 
being implemented by the European Commission to support their development.
In Italy, a National Registry of rare diseases has been established in 2001 as a network of regional 
registries. The latter have gradually been established and the full coverage of the Italian territory was 
attained during 2011.
Methods. Here we describe the basic features of the National Registry of rare diseases; the 
activities carried out to promote consistent operations in the regional registries; and the overall quality 
and composition of the records collected.
Results. After a validation process, including removal of duplicate records, 110,841 records of 
patients with rare diseases, single and with group denominations, are stored in the National Registry 
of rare diseases. They correspond to the overall diagnoses communicated to national registry by 
regional registries up to 30 June 2012.
The quality of the data collected by the the National Registry of rare diseases has been assessed 
with respect to completeness and consistency of procedures. Variables characterising case and 
diagnosis showed a very limited number of missing values. Records reported at least one case of 
485 rare conditions.
Discussion. To date, the National Registry of rare diseases is a surveillance system with the main 
objective of producing epidemiologic evidence on rare diseases in Italy, and of supporting policy 
making and health services planning. 
Data quality still represents a limitation for any sound epidemiological estimate of rare diseases 
in Italy. However, improvements of the quality of collected data and the completeness of case 
notifications should be strengthened.
Keywords: Italy, rare diseases, registry, public health.
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Methods
Legal basis, integration in the health system and 
scope of the RNMR
The RNMR has been established at the National 
Institute of Health by Ministerial Decree (MD) in 2001 
as part of the measures devoted to improve health 
care for RD patients9. Indeed, it also envisaged the 
establishment, at regional or interregional level, of a 
network of formally designated centres (FDCs) with 
recognised expertise on RD, which could carry out 
the confirmatory investigations free of charge for the 
suspect patient, ensure a better and more effective 
patient management and ascertain the right of the patient 
to RD clinical assistance and treatments. This decree 
made reference to a list of 314 individual RD identified 
with own codes and 52 groups and subgroups of RD 
with group codes. Within these groups, 160 example 
pathologies were mentioned. The RNMR mandate was 
to monitor RD and inform the national and regional 
planning of measures for the protection of RD patients. 
The decree also explicitly mentioned the faculty for 
RNMR to liaise with international registries and to 
collect demographic, anamnesis, clinical, laboratory, 
determinant data of use for medical, biomedical and 
epidemiological research. Patient pseudonymization and 
the possibility of patient tracing in case of need were 
allowed in compliance with data protection legislation. 
Due to the devolved organisation of the Italian health 
system, which gives the Regions the responsibility for 
the delivery of health services, the MD provided that the 
RNMR was functionally linked to RRs, which were to 
be established by regional authorities. Two agreements 
between the Central Government and the Regional 
Authorities, in 2002 and 2007, ensured the coordinated 
implementation of the RRs, defining the set of variables 
and the procedures for the data communication between 
the RRs and the RNMR10,11.
Establishment of regional registries
Following the MD, to ensure the delivery of RD 
special assistance, the regional authorities proceeded 
to the designation of their FDCs on the basis of criteria 
related to competence in the diagnosis, care and 
treatment of RD and to the availability of appropriate 
complementary services. Subsequently, the regional 
authorities established the RRs with regional decrees 
and other regulations, which ensured the necessary 
infrastructures as well as the legitimacy and security 
of the data flow from the FDCs to the corresponding 
RRs in compliance with the personal data protection 
legislation. In many cases, specific information systems 
have been developed at regional level with the aim of 
supporting the data collection and in some cases, the 
delivery of health care services to RD patients. The RRs 
may differ in aims and internal organisation: some have 
mainly epidemiological and public health purposes, in 
support of regional planning, while others also aim at 
evaluating health services and diagnostic procedures, or 
are integrated in the regional health care delivery system. 
Data set and data communication 
A common data set for the communication of data 
from the RRs to the RNMR was defined to fulfil the 
mandate of RNMR. This set is detailed in Table I. The 
diagnosis was expressed according to the exemption 
code attributed by the MD. The RRs sent RNMR the 
data batches regarding confirmed diagnoses made by 
their FDCs in each semester of the calendar year. Data 
communication took place normally during January 
and July. This practice is changing to an annual transfer 
based on whole calendar years.
 Table I - The common data set of the RNMR.
Variables Reason
ID (encrypted code based on given 
name, family name, birth date and 
place, sex)
Avoid multiple registrations of the 
same patient; conduct any type of 
record linkage
Sex Epidemiologic analysis
Date of birth Age at disease onset, diagnosis, death
Place of residence Prevalence, geographical distribution, 
patient mobility
Live - dead condition Prevalence
Date of death Prevalence; age at death
Diagnosis of rare disease Epidemiologic analysis
Date of diagnosis Incidence; diagnosis delay
Centre of RD diagnosis Patient mobility; health service 
utilization
Date of disease onset Incidence; diagnosis delay
Orphan drug used Treatment monitoring
Training of the operators
Statisticians and computer technicians of the RNMR 
have held training courses from 2002 to 2009 to the 
Regions without a proprietary rare diseases registry to 
introduce the operators of the RRs to the proprietary 
software developed by CNMR and to standardize the 
methods used to collect the data throughout the country.
Quality control procedures 
Experts in each RRs were responsible for the 
validation of the data of the corresponding FDCs. Some 
information systems supporting registries allow quality 
data control at the moment of the data entry by users. 
Furthermore, quality control processes are regularly 
carried out by RRs staff. In addition, at national level, the 
quality control of the common data set was carried out on 
the whole database in two steps by the RNMR operators. 
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The first step consisted of a control of duplicate records, 
logical inconsistencies and range errors on individual 
data batches sent by the RRs. In case that range errors 
or logical inconsistencies were found, the records were 
sent back to the RRs for a check with the regional data 
sources. Inconsistencies and range errors which were not 
resolved after this control were considered as missing 
data. The second step was carried out on the database 
resulting from the merging of the regional data batches. 
In particular, this procedure checked for possible 
duplicates coming from different RRs and a specific 
protocol for the management of duplicate records was 
followed as shown in Table II. As shown in this table, 
the record management was dependent on the type of 
duplication and different record extractions were carried 
out depending on the scope of the analyses. 
Periodic meetings and reporting
The experts responsible for the RRs convened 
yearly to report on achievements and experience in the 
management of their registries and to discuss common 
issues. In 2012, the RNMR, in collaboration with 
the RRs, prepared its first annual report12, where the 
main features of the RRs and of the data quality were 
described. 
Compliance with personal data protection Regulations
Each regional registry collects information on patients 
according to the national data protection law. When part 
of the data collected by RRs are communicated to the 
RNMR, an algorithm is used for the secure transfer 
of information. The data transmission took place by 
means of a temporary channel opened temporarily for 
this purpose and the personal data were transmitted 
Table II - Description and process management of duplicate records.
Duplicate type 1 Duplicate type 2 Duplicate type 3
Description Records with same ID, diagnosis 
and diagnostic centre.
Records with same ID and diagnosis 
and different diagnostic centre for 
RDs. 
Records with same ID and different 
rare disease diagnosis.
Presumed cause Additional notifications are made of 
a case already notified.
The case was diagnosed in two 
or more different centres, which 
notified the case. 
The case is affected by more RDs. 
Record management
Aim of analysis
Analysis of the activity of 
diagnosis centres
Only the record with less recent 
diagnosis is considered. 
The other records are discarded.
All records are considered. 
No records are discarded.
All records are considered. 
No records are discarded.
Analysis of cases recorded in the 
RNMR
Only the record with less recent 
diagnosis is considered. 
The other records are discarded.
Only the record with less recent 
diagnosis is considered. 
No records are discarded.
Only the record with less recent 
diagnosis is considered. 
No records are discarded.
Analysis of RDs recorded in the 
RNMR
Only the record with less recent 
diagnosis is considered. 
The other records are discarded.
Only the record with less recent 
diagnosis is considered. 
No records are discarded.
All records are considered. 
No records are discarded.
Number of duplicate records 3,322 3,393 2,483
separately from sensitive data. Personal and sensitive 
data were stored in separate servers of the informatics 
service of the National Institute of Health, protected with 
advanced firewall and technological systems.
Results
The geographic coverage of RNMR 
When the MD was put into effect, a RR of RD 
patients was in operation in the Veneto region only. Since 
then, RRs were progressively established and connected 
to the RNMR (Figure 1). The 2007 Agreement between 
Central Government and the Regions11, triggered a 
significant acceleration of the process (Figure 2) and the 
full coverage of the Italian territory connected with the 
RNMR was achieved during 2011. The establishment 
of the RRs resulted in a significant increase of the cases 
communicated to the RNMR, which approximately 
paralleled the increase in the nominal population 
coverage calculated from the official resident population 
of the regions. 
Quality of the common data set 
Up to 30 June 2012, 112,766 records of RD 
patients were communicated to the RNMR. During 
the subsequent validation process, 25 records showed 
missing values for diagnosis or ID code or missing date 
of birth or sex. After check with the RRs, 17 records were 
discarded and 8 records were retained for subsequent 
processing. The remaining set of 112,749 records 
were checked for the presence of duplicate records, 
i.e., multiple records of a same patient received from 
different RRs and managed depending on the type of 
duplication as reported in Table II, which also shows the 
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results of this analysis. Discarded Type 1 records, which 
represent true duplicates, were 1 908, corresponding to 
1.7% of the total valid records. Therefore the cleaned 
database was made of 110,841 records. 
The quality of the data collected by the RNMR 
has been assessed with respect to completeness and 
consistency of procedures. Table III summarizes the 
results of this control for each variable of the common 
data set. While completeness analysis was based on the 
observation of the database records, the assessment of 
consistency of procedures summarizes the discrepancies 
emerged during the preparation of the first RNMR 
report. The variables characterizing case and diagnosis 
showed a very limited number of missing values and a 
remarkable improvement could be observed, during time, 
in the completeness of recording of the centre making 
diagnosis. It is often the case with registries, that the 
date of death of patients is not collected systematically 
and timely by registry data providers. Although some 
records reported live cases with unrealistic age, there 
was no criterion that the RNMR could use to spot all 
records that did not update this information regularly. 
 
Figure 1 -  Establishment of regional RD registries in Italy.
 The year indicated refers to the year of institution of the registry.
The date of disease onset is largely and persistently 
incomplete. An analysis of the records showed that 
missing data were mostly associated with some RRs. 
Indeed, while it is difficult to define the date of the 
symptoms onset in the case of patients affected by a 
rare diseases since a long time, or when the first signs or 
symptoms of a rare diseases are unspecific, some RRs do 
not collect this data. The completeness of data regarding 
the use of orphan drugs was assessed as follows. At first, 
the diseases were identified, for which an indication of 
use of orphan drugs was given; then, making reference 
to all the records of each of the diseases so identified, the 
fraction of records with missing values was calculated. 
This analysis indicated that, in the whole database, 
treatments were indicated for 56 conditions and that 
incomplete records (i.e. records which do not show the 
indication of a drug nor the explicit indication of no drug 
use) represented 14.9%. The lack of this data showed 
a marked decrease with time, indicating the steady 
improvement in its collection. Table 3 also summarizes 
the observations regarding the accuracy of the minimum 
set of data collected by RNMR. 
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Figure 2 - Nominal population coverage of the RNMR and notification flow.
 The year indicated refers to the institution of the regional registry. Notifications reported for the year 2012 
refer to the first half of the year.
Table III - Completeness and accuracy of the common dataset.
Common data set Completeness (% missing)a Accuracy
Whole 
database
(110,841 records)
Calendar years 
2010-2011
(27,114 records)
Calendar year 
2012 
(6 months)
(9,913 records)
Gender 0.0 0.0 0.0 Data is collected consistently among  data sources according to usual 
identification procedures
Date of birth 0.0 0.0 0.0 Data is collected consistently among  data sources according to usual 
identification procedures
Region of residence 0.1 0.1 0.0 Data is collected consistently among  data sources according to usual 
identification procedures
Diagnosis 0.0 0.0 0.0 Diagnoses are controlled and validated by the RRsb and their accuracy rely 
on the selection criteria for the centres to become FDC of the RD network
Date of diagnosis 1.0 -- -- Inconsistencies among regions on the identification of the relevant 
diagnostic event and diagnostic centre. 
Centre of RD 
diagnosis 
11.9 1.2 0.4 Inconsistencies among regions on the identification of the relevant 
diagnostic event and diagnostic centre. A centre may change name 
following reorganisation.
Vital status ND ND ND c Uncertainties in this variable depend on the fact that the data sources of 
RRsb may not be fully aware of the reason why patients are lost to follow 
up. In the future, date of decease will be collected from death registries: 
this will result in a systematic and precise, although delayed, appraisal 
of this condition.
Date of decease ND ND ND Expectedly good (when reported). In the future, date of decease will be 
collected from death registries: this will result in a systematic and precise, 
although delayed, appraisal of this condition.
Date of  disease onset 46.4 57.1 81.4 Uncertainties in this variable depend on i) lack of patient's recollection; 
ii) gradual appearance of unspecific symptoms over a long period. 
Symptoms could also not set on due to effective treatment following 
early diagnosis (e.g. following neonatal screening)
Orphan drug used 14.9 10.7 4.6 The name of the active substance is communicated, but no standard 
catalogue or coding  is used.
a Data completeness is measured as the proportion (%) of records without the indication of the value of the variable; calendar years refer to the date of 
diagnosis; b Regional registry; c ND = not determined
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Preliminary results after the start of activity with full 
nominal coverage of the national territory
Altogether, the valid records which are stored at present 
into RNMR are 110.841. This number corresponds to 
the overall diagnoses communicated to RNMR up to 30 
June 2012 by RRs which have started their collection at 
different dates between 2000 and the end of 2011. The 
records referred to diagnoses made in the first 6 months 
of 2012, with RRs covering all the national territory, were 
9,913. Although these features prevent, at present, any 
sound epidemiological estimate of rare diseases in Italy, 
some observations on the composition of the rare diseases 
notifications communicated to RNMR, may be of interest. 
Table IV shows the distribution, across the ICD 9-CM 
Chapters, of the diagnoses notified to the RNMR. The RDs 
under this surveillance system include conditions named 
individually and with group denominations. Altogether, 
the records reported at least one case of 485 conditions. 
All groups and subgroups mentioned in the MD were 
represented, making up 58,942 records, including 7,328 
records of 137 pathologies mentioned as examples. 
Besides these, 296 individual RDs were represented with 
51,899 records. Of these records, about 50% were made 
up by 15 most frequent diseases: achalasia, amyotrophic 
lateral sclerosis, behçet disease, bullous pemphigoid, 
chronic inflammatory demyelinating polyneuropathy, 
down syndrome, hereditary hemorrhagic telangiectasia, 
idiopathic central precocious puberty, keratoconus, 
Klinefelter syndrome, Lambert-Eaton syndrome, Marfan 
syndrome, mixed cryoglobulinemia, pemphigus, Turner 
syndrome. Twenty-nine diseases were represented with 
one record only.
Discussion
The European Commission Communication: "Rare 
diseases: Europe's challenge"2 and the subsequent Council 
Recommendation7 emphasize the strategic importance of 
Patient Registries in the field of RD. 
The national network of Centres, identified at regional 
and interregional level, and of Regional/Interregional 
Registries dedicated to RD, was successfully implemented 
in Italy following the MD and the agreements between 
the Government and the Italian regions. To date, the 
Italian RNMR is a surveillance system, with the the main 
objective of producing epidemiologic evidence on RD in 
Italy, and of supporting policy making and HS planning. 
This role of the RNMR has been confirmed by the draft 
National Plan on RD, recently proposed for public 
consultation by the Ministry of Health13. Considering the 
complexity of building such registries in a devolved system 
of responsibility for healthcare delivery, substantial efforts 
were necessary in various steps of RNMR development, 
especially at regional level where the supporting 
infrastructures had to be established.
The strong legal base, its integration in the public health 
service and its connection with the dedicated national RD 
patient protection policy ensures the registry stability, 
comprehensiveness and population coverage. However, 
the need to cope with different levels of local resources, 
the slow responsiveness and limited flexibility typical 
of institutional processes as well as the need to rely on 
quality and comparable data made the implementation of 
the RNMR a slow and stepwise process, which is far from 
being concluded. The common data set agreed among 
the central and regional health authorities, is indeed the 
result of a selection of data, the collection of which could 
be sustainable, made comparable and be used to provide 
information coherent with the national scope of the 
RNMR, as distinct from the regional level responsibilities. 
During the gradual establishment of the Regional 
RD registries, which achieved nominal completion 
during 2011, a steadily increasing flow of data on RD 
patients was established from the RRs to the RNMR. 
Moreover, we could observe also a continuously increasing 
involvement of the operators of the RD registry system. 
To achieve this result, an important role was played by 
the dedicated training courses in the regions which do not 
have a proprietary Rare Diseases Registry, conducted in a 
systematic way by the experts of the RNMR.
The preparation of the first Report on the RNMR 
activity9, in collaboration with the RRs, turned to be a 
powerful tool to review the operation of this complex 
system and to highlight the need for a number of critical 
improvements. The collection of the vital status and death 
date should be undertaken systematically. To this aim, the 
Table IV - Distribution, across the ICD 9-CM Chapters, of 
diseases notified to RNMR up to 30 June 2012. 
 ICD 9-CM Chapters Percent 
records
1. Infectious and parasitic diseases 0.1
2. Neoplasms 5.0
3. Endocrine, nutritional, and metabolic diseases, and 
immunity disorders
17.4
4. Diseases of the blood and blood-forming organs 16.6
6. Diseases of the central nervous system and sense 
organs
26.0
7. Diseases of the circulatory system 4.3
9. Diseases of the digestive system 1.3
10. Diseases of the genitourinary system 0.6
12. Diseases of the skin and subcutaneous tissue 3.3
13. Diseases of the musculoskeletal system and 
connective tissue
5.5
14. Congenital anomalies 19.7
15. Certain conditions originating in the perinatal period 0.1
16. Symptoms, signs, and ill-defined conditions 0.0
Total 100
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RNMR is seeking access to the national database of death 
records. Moreover, the inconsistencies in the collection 
of the disease onset date and the adoption of improved 
definitions of the diagnostic event relevant to determine the 
date of diagnosis and the centre making diagnosis are being 
discussed. Finally a more accurate list of active substances 
is to be adopted. The procedures used to validate records 
and to control data completeness also should be better 
distributed between the RNMR and the RRs to make the 
data flow a smooth process. 
The actual coverage of the population depends on the 
quality and functions of the information systems developed 
at regional or interregional level. The different lengths of 
periods of operation of the RRs (ranging from about 1 to 
more than 10 years) result in different effectiveness of the 
registration process and only some regions collect data 
on RD patients using multiple data sources. Therefore, 
with the progressive improvement of RRs operations, 
the heterogeneity of the case reporting completeness will 
become less and less relevant. However, this issue has to 
be assessed and addressed appropriately. 
At present, therefore, the data currently stored in 
the RNMR represents the baseline for a continuous 
improvement of the national and RRs and to start a 
validation process through the comparison of the RNMR 
results with studies in other population groups. For an 
overall improvement of the Italian RD surveillance 
system, CNMR is promoting collaborations with National 
statistical services, clinicians, patient associations and 
other data sources. Moreover, additional opportunities for 
improvement will come from the participation of CNMR 
and other experts of the Italian RD network in other 
European and global initiatives, such as the European 
Platform for rare disease registries (EPIRARE: www.
epirare.eu), the International Rare Disease Research 
Consortium, (IRDiRC: www.irdirc.org) and the Integrated 
Platform connecting databases, registries, biobanks and 
clinical bioinformatics for Rare Disease research (RD-
Connect:www.rd-connect.eu. 
The Authors declare no conflicts of interest.
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